Heart failure, chronic, diastolic, (preserved ejection fraction): Long-term mortality (fatal outcome)
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2006 Jul 20;355(3):260-9 Cohorts
IN heart failure, chronic, diastolic (preserved ejection fraction) The Use of
age, female, history of hypertension and atrial fibrillation
As Etiologic risk factor
Is useful Than
no comparison here
To be associated to heart failure with preserved ejection fraction. Mortality at 1 year was not different from heart failure with reduced ejection fraction: 22% preserved VS 26% reduced.
N Engl J Med. 2006 Jul 20;355(3):251-9 Cohorts
IN heart failure, chronic, diastolic (preserved ejection fraction) The Use of
prevalence over time, mortality, presence of associated hypertension, atrial fibrillation, and diabetes
As Etiologic risk factor
Is useful Than
no comparison here
To underscore the importance of this disease: prevalence increased over a 15-year period, being presently 47% of all new heart failures. Mortality was the same that systolic heart failure and it did not improve over time
Eur J Heart Fail. 2009 Sep;11(9):855-62 Meta-Analysis
IN heart failure, chronic, diastolic (preserved ejection fraction) The Use of
long term mortality (fatal outcome)
As Prognostic Item
Is better Than
sytolic (impaired ejection fraction) heart failure
To know natural history and adapt therapy: death at 4 years was lower in case of diastolic (32%) than systolic (41%) heart failure.